Dalgic A, Dinc M E, Ulusoy S, Dizdar D, Is A, Topak M
Department of Otolaryngology, Head and Neck Surgery, Istanbul Gaziosmanpasa Taksim Research and Training Hospital, 34255 Istanbul, Turkey.
Department of Otolaryngology, Head and Neck Surgery, Istanbul Gaziosmanpasa Taksim Research and Training Hospital, 34255 Istanbul, Turkey.
Eur Ann Otorhinolaryngol Head Neck Dis. 2017 Sep;134(4):213-216. doi: 10.1016/j.anorl.2016.05.012. Epub 2017 Jan 18.
Olfactory dysfunction is one of the comorbidities associated with allergic rhinitis (AR) and AR is one of the common causes of olfactory problems. We aimed to evaluate by the Sniffin' Sticks test the effects on olfactory functions of nasal steroids and leukotriene antagonists used for allergic rhinitis.
Thirty patients with seasonal rhinitis were included in this study. Patients were randomly divided into three groups of 10 patients; group 1 received montelukast sodium and mometasone furoate (MF) therapy, group 2 received only montelukast, and group 3 only MF. Patients' olfactory functions were determined using the Sniffin' Sticks olfactory test before and after a month treatment.
Threshold, discrimination, identification, and the sum of threshold, discrimination, and identification (TDI) values were not significantly different among the groups before treatment. For Group 1 and Group 3 patients, there were statistically significant differences in threshold, discrimination, identification, and TDI values before and after treatment (P<0.05) (Wilcoxon signed ranks analysis). For Group 2 patients, the before and after treatment values of threshold, discrimination, identification, and TDI showed no significant difference (P>0.05).
According to the findings of our study, MF is superior to montelukast in improving olfactory function. Although montelukast has been shown to be effective against AR symptoms, its effect on olfactory function was not demonstrated in this study.
嗅觉功能障碍是变应性鼻炎(AR)的合并症之一,而AR是嗅觉问题的常见原因之一。我们旨在通过嗅棒测试评估用于变应性鼻炎的鼻用类固醇和白三烯拮抗剂对嗅觉功能的影响。
本研究纳入了30例季节性鼻炎患者。患者被随机分为三组,每组10例;第1组接受孟鲁司特钠和糠酸莫米松(MF)治疗,第2组仅接受孟鲁司特治疗,第3组仅接受MF治疗。在治疗前和治疗一个月后,使用嗅棒嗅觉测试确定患者的嗅觉功能。
治疗前各组之间的阈值、辨别力、识别力以及阈值、辨别力和识别力之和(TDI)值无显著差异。对于第1组和第3组患者,治疗前后的阈值、辨别力、识别力和TDI值存在统计学显著差异(P<0.05)(Wilcoxon符号秩分析)。对于第2组患者,阈值、辨别力、识别力和TDI的治疗前后值无显著差异(P>0.05)。
根据我们的研究结果,MF在改善嗅觉功能方面优于孟鲁司特。尽管孟鲁司特已被证明对AR症状有效,但本研究未证明其对嗅觉功能的影响。